THU0411 Secukinumab Efficacy in Anti-TNF-Naive and Anti-TNF-IR Patients with Psoriatic Arthritis: Results of a Phase 3 Multicenter, Double-Blind, Placebo-Controlled Study (Future 2)
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 345.3-346
◽
Keyword(s):
Phase 3
◽